Episode Details

Back to Episodes
Ep 127: Phase 1 trial finds iPSC-derived neural progenitors safe in subacute spinal cord injury over 2–4 years of follow-up.

Ep 127: Phase 1 trial finds iPSC-derived neural progenitors safe in subacute spinal cord injury over 2–4 years of follow-up.

Season 1 Episode 127 Published 1Β month, 1Β week ago
Description
Planetterrian Daily 🌍 Planetterrian Daily - Science, Longevity & Health Discoveries Phase 1 trial finds iPSC-derived neural progenitors safe in subacute spinal cord injury over 2–4 years of follow-up. Top 15 Science & Health Discoveries Endothelial NOD2 signaling shapes intestinal T-cell responses β€” Nature Immunology Endothelial cells carrying intrinsic NOD2 drive generation of effector and memory T cells that regulate gut immunity. ... AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. πŸ“ Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network β€” explore every show at nerranetwork.com.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us